Condition: Idiopathic Hypersomnia · Sponsor: Harmony Biosciences Management, Inc.
This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in adult participants (ages ≥18 years) with idiopathic hypersomnia (IH).
This description comes directly from the study's public registry record.
Katie Wilmsen · 443-309-5556 · clinicaltrials@harmonybiosciences.com
Michelle Manuel · 847-903-4610 · clinicaltrials@harmonybiosciences.com
Always discuss trial participation with your own doctor first.
| Sleep Disorders Center of Alabama | Birmingham, Alabama, United States | Recruiting |
| Stanford Center for Sleep Medicine | Redwood City, California, United States | Recruiting |
| Santa Monica Clinical Trials | Santa Monica, California, United States | Recruiting |
| Alpine Clinical Research Center, Inc. | Boulder, Colorado, United States | Recruiting |
| PharmDev Research Institute, LLC | Miami, Florida, United States | Recruiting |
| Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC) | Winter Park, Florida, United States | Recruiting |
| NeuroTrials Research Inc. | Atlanta, Georgia, United States | Recruiting |
| Sleep Practitioners, LLC | Macon, Georgia, United States | Recruiting |
| Phillip Nowlin | Stockbridge, Georgia, United States | Recruiting |
| Revive Research Institute | Southfield, Michigan, United States | Recruiting |
| St. Luke's Hospital, Sleep Medicine and Research Center | Chesterfield, Missouri, United States | Recruiting |
| Clinical Research of Gastonia | Gastonia, North Carolina, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07500090